Sagespring Wealth Partners LLC grew its position in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 10.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 50,649 shares of the company's stock after acquiring an additional 4,596 shares during the quarter. Sagespring Wealth Partners LLC's holdings in Procter & Gamble were worth $8,632,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of the company. Cladis Investment Advisory LLC increased its holdings in shares of Procter & Gamble by 5.2% in the 4th quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock valued at $806,000 after purchasing an additional 236 shares during the period. FAS Wealth Partners Inc. lifted its position in Procter & Gamble by 2.0% in the fourth quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company's stock worth $4,642,000 after purchasing an additional 549 shares during the period. Berkshire Asset Management LLC PA raised its stake in Procter & Gamble by 0.9% during the fourth quarter. Berkshire Asset Management LLC PA now owns 236,616 shares of the company's stock worth $38,833,000 after acquiring an additional 2,179 shares in the last quarter. Strategic Advisors LLC increased its stake in shares of Procter & Gamble by 3.4% in the fourth quarter. Strategic Advisors LLC now owns 55,912 shares of the company's stock valued at $9,374,000 after buying an additional 1,818 shares in the last quarter. Finally, Natural Investments LLC acquired a new stake in Procter & Gamble in the fourth quarter worth about $2,121,000. Institutional investors and hedge funds own 65.77% of the company's stock.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CEO Jennifer L. Davis sold 1,000 shares of the company's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the sale, the chief executive officer now owns 51,965 shares of the company's stock, valued at approximately $8,386,111.70. This represents a 1.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the stock in a transaction on Monday, May 5th. The stock was sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the sale, the insider now directly owns 25,182 shares of the company's stock, valued at $3,995,627.94. This represents a 29.47% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.18% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on PG shares. Redburn Partners set a $161.00 price objective on Procter & Gamble in a report on Thursday, May 1st. Royal Bank of Canada raised Procter & Gamble from a "sector perform" rating to an "outperform" rating and upped their price objective for the company from $164.00 to $177.00 in a report on Friday, April 25th. Raymond James dropped their price objective on Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating for the company in a research report on Friday, April 25th. Bank of America dropped their target price on Procter & Gamble from $190.00 to $180.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Finally, Erste Group Bank cut Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Eight analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of "Moderate Buy" and an average target price of $178.86.
Read Our Latest Analysis on Procter & Gamble
Procter & Gamble Stock Down 1.9%
Shares of NYSE PG opened at $160.06 on Monday. The Procter & Gamble Company has a 12-month low of $156.58 and a 12-month high of $180.43. The company has a market cap of $375.27 billion, a P/E ratio of 25.49, a P/E/G ratio of 3.76 and a beta of 0.43. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The stock has a fifty day moving average price of $163.75 and a 200 day moving average price of $166.64.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.53 by $0.01. The company had revenue of $19.78 billion for the quarter, compared to analyst estimates of $20.42 billion. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. Procter & Gamble's revenue was down 2.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.52 earnings per share. Research analysts anticipate that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Monday, April 21st were given a dividend of $1.0568 per share. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.01. The ex-dividend date of this dividend was Monday, April 21st. This represents a $4.23 dividend on an annualized basis and a yield of 2.64%. Procter & Gamble's payout ratio is currently 66.98%.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.